CFGS
RCEL icon

Concourse Financial Group Securities’s Avita Medical RCEL Stock Holding History

Concourse Financial Group Securities’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$1.84K – 2393
2021
Q4 		$2K Hold
200
– – ﹤0.01% 2220
2021
Q3 		$4K Hold
200
– – ﹤0.01% 2133
2021
Q2 		$4K Hold
200
– – ﹤0.01% 2095
2021
Q1 		$4K Hold
200
– – ﹤0.01% 2024
2020
Q4 		$4K Hold
200
– – ﹤0.01% 1984
2020
Q3 		$5K Hold
200
– – ﹤0.01% 1802
2020
Q2 		$6K Hold
200
– – ﹤0.01% 1638
2020
Q1 		$6K Buy
+200
New +$8.28K ﹤0.01% 1612

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Concourse Financial Group Securities's RCEL Position: Q1 2022 in Review

Concourse Financial Group Securities sold out of Avita Medical (RCEL) in Q1 2022, closing a stake of 200 shares — an estimated $1.84K sold.

Concourse Financial Group Securities first reported a position in RCEL in Q1 2020 and held it in 8 quarters. The position peaked at $6K in Q2 2020. 68 funds tracked by Wall St. Rank hold RCEL as of Q1 2022.

  • Concourse Financial Group Securities reported no remaining Avita Medical position as of Q1 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 200 Avita Medical shares in Q1 2022, an estimated $1.84K.
  • Concourse Financial Group Securities first reported a position in Avita Medical in Q1 2020 and held it in 8 quarters.
  • Concourse Financial Group Securities's Avita Medical position peaked at $6K in Q2 2020.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.